H.B. Fuller (NYSE:FUL) Receives Average Rating of “Hold” from Brokerages

H.B. Fuller (NYSE:FUL) has been given an average rating of “Hold” by the six ratings firms that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and one has given a buy recommendation to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $75.60.

A number of equities research analysts have recently issued reports on FUL shares. Deutsche Bank Aktiengesellschaft cut their target price on H.B. Fuller from $75.00 to $72.00 and set a “buy” rating on the stock in a research report on Wednesday, January 22nd. Vertical Research downgraded H.B. Fuller from a “buy” rating to a “hold” rating in a report on Monday, January 6th. Seaport Res Ptn cut shares of H.B. Fuller from a “strong-buy” rating to a “hold” rating in a report on Wednesday. JPMorgan Chase & Co. cut their price target on shares of H.B. Fuller from $70.00 to $60.00 and set an “underweight” rating on the stock in a report on Friday, January 17th. Finally, Citigroup decreased their price objective on shares of H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating for the company in a research note on Friday, January 3rd.

H.B. Fuller Stock Down 0.1 %

FUL opened at $57.07 on Friday. H.B. Fuller has a one year low of $54.18 and a one year high of $87.67. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.16 and a current ratio of 1.81. The company has a market capitalization of $3.12 billion, a PE ratio of 24.70, a P/E/G ratio of 1.13 and a beta of 1.41. The stock’s fifty day moving average is $61.30 and its 200-day moving average is $71.82.

H.B. Fuller (NYSE:FUL) last released its earnings results on Wednesday, January 15th. The specialty chemicals company reported $0.92 EPS for the quarter, missing the consensus estimate of $1.00 by ($0.08). The business had revenue of $923.00 million for the quarter, compared to analyst estimates of $916.84 million. H.B. Fuller had a net margin of 3.65% and a return on equity of 12.01%. The firm’s revenue for the quarter was up 2.2% on a year-over-year basis. During the same period in the prior year, the company earned $1.32 earnings per share. On average, equities analysts predict that H.B. Fuller will post 4.07 EPS for the current fiscal year.

H.B. Fuller Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, February 20th. Investors of record on Thursday, February 6th were given a dividend of $0.2225 per share. This represents a $0.89 dividend on an annualized basis and a yield of 1.56%. The ex-dividend date was Thursday, February 6th. H.B. Fuller’s payout ratio is presently 38.53%.

Institutional Investors Weigh In On H.B. Fuller

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Lord Abbett & CO. LLC increased its stake in shares of H.B. Fuller by 79.8% in the third quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock worth $57,952,000 after acquiring an additional 324,056 shares during the last quarter. Geode Capital Management LLC grew its stake in H.B. Fuller by 1.5% in the third quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock valued at $99,939,000 after purchasing an additional 18,734 shares in the last quarter. S&CO Inc. increased its position in H.B. Fuller by 0.3% in the 3rd quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company’s stock worth $21,209,000 after purchasing an additional 920 shares during the last quarter. Wesbanco Bank Inc. raised its stake in shares of H.B. Fuller by 41.2% during the 4th quarter. Wesbanco Bank Inc. now owns 13,700 shares of the specialty chemicals company’s stock worth $924,000 after purchasing an additional 4,000 shares in the last quarter. Finally, MetLife Investment Management LLC lifted its holdings in shares of H.B. Fuller by 4.7% during the 4th quarter. MetLife Investment Management LLC now owns 33,058 shares of the specialty chemicals company’s stock valued at $2,231,000 after buying an additional 1,472 shares during the last quarter. Hedge funds and other institutional investors own 95.93% of the company’s stock.

H.B. Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.